Ancillary fish analysis for 1p and 19q status: Preliminary observations in 287 gliomas and oligodendroglioma mimics

被引:103
作者
Perry, A
Fuller, CE
Banerjee, R
Brat, DJ
Scheithauer, BW
机构
[1] Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63110 USA
[2] Emory Univ Hosp, Div Neuropathol, Atlanta, GA 30322 USA
[3] Mayo Clin, Div Neuropathol, Rochester, MN USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2003年 / 8卷
关键词
astrocytoma; brain tumors; chromosome; 1; 19; dysembryoplastic neuroepithelial tumor; genetics; in situ hybridization; loss of heterozygosity; neurocytoma; oligodendroglioma; prognosis; review;
D O I
10.2741/896
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deletions of chromosomes 1p and 19q are associated with chemosensitivity and enhanced survival in oligodendrogliomas. Therefore, we have utilized FISH analysis as an ancillary tool for diffuse gliomas with suspected oligodendroglial features. To date, 246 gliomas have been analyzed in 131 male and 93 female patients, including 109 oligodendrogliomas (O), 109 mixed oligoastrocytomas / equivocal gliomas (MOA), and 28 astrocytomas (A). To address specificity, we also analyzed 41 oligodendroglioma mimics, including 12 central and 12 extraventricular neurocytomas (EVN), 12 dysembryoplastic neuroepithelial tumors, and 5 clear cell ependymomas. Aside from 2 EVNs, no mimics demonstrated codeletion. Three patterns were associated with glioma cell type (O vs. MOA/A): -1p/19q, -19q alone, and polysomies. Long-term survivals of >5-years (N=47) and >10-years (N=16) were associated with 1p/19q codeletion in 60% and 75% respectively, whereas solitary 19q deletion accounted for 11% and 6% respectively. Survivals <2-years (N=10) were associated with lack of deletions in 70%. A few older patients with high-grade, "genetically favorable" tumors did poorly, whereas prolonged survival was observed in several low-grade glioma patients despite a lack of the "genetically favorable" pattern. Our data suggests that: 1) FISH-detectable 1p/19q codeletion is relatively specific for oligodendrogliomas with long survival, 2) solitary 19q deletion may also portend a favorable prognosis in a smaller subset, and 3) combined clinicopathologic and genetic assessment likely provides a more accurate means of patient stratification than either one alone.
引用
收藏
页码:A1 / A9
页数:9
相关论文
共 52 条
  • [1] Aldape K, 2000, CANCER-AM CANCER SOC, V88, P2342, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2342::AID-CNCR19>3.0.CO
  • [2] 2-X
  • [3] [Anonymous], 2000, World Health Organisation Classification of Tumours: Pathology and genetics of tumours of the nervous system
  • [4] [Anonymous], RESEARCH-CHINA, V47, P178, DOI [10.1177/0093650218777177, DOI 10.1177/0093650218777177, DOI 10.1177/106689699400200109]
  • [5] Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas
    Balesaria, S
    Brock, C
    Bower, M
    Clark, J
    Nicholson, SK
    Lewis, P
    de Sanctis, S
    Evans, H
    Peterson, D
    Mendoza, N
    Glaser, MG
    Newlands, ES
    Fisher, RA
    [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (08) : 1371 - 1377
  • [6] Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas
    Bauman, GS
    Ino, Y
    Ueki, K
    Zlatescu, MC
    Fisher, BJ
    Macdonald, DR
    Stitt, L
    Louis, DN
    Cairncross, JG
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03): : 825 - 830
  • [7] BELLO MJ, 1995, INT J CANCER, V64, P207
  • [8] Bortolotto S, 2000, INT J CANCER, V88, P554, DOI 10.1002/1097-0215(20001115)88:4<554::AID-IJC6>3.0.CO
  • [9] 2-Q
  • [10] Bruner JM, 1997, CANCER, V79, P796, DOI 10.1002/(SICI)1097-0142(19970215)79:4<796::AID-CNCR17>3.0.CO